Nuclear hormone receptor ligand binding domains
CA 2439196 A1 · Owner: Phelps, Christopher Benjamin · Inventors: Phelps, Christopher Benjamin; Fagan, Richard Joseph
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to the novel proteins termed LBDG1 and LBDG4, herein , identified as Nuclear Hormone Receptor Ligand Binding Domains and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 5, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 5, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 5, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.